In the BioHarmony Drug Report Database

"Preview" Icon

Lactic acid

Phexxi (lactic acid) is a small molecule pharmaceutical. Lactic acid was first approved as Phexxi on 2020-05-22. It is used to treat dermatitis and facial dermatoses in the USA. It is known to target hydroxycarboxylic acid receptor 1. Prismasol bgk2/0’s patents are valid until 2033-03-15 (FDA).

 

Trade Name

 

Phexxi
 

Common Name

 

lactic acid
 

ChEMBL ID

 

CHEMBL1200559
 

Indication

 

dermatitis, facial dermatoses
 

Drug Class

 

Image (chem structure or protein)

Lactic acid structure rendering